NextGen Healthcare (NXGN) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" NXGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares.
View NXGN analyst ratings or view top-rated stocks.

7 equities research analysts have issued 1-year price objectives for NextGen Healthcare's stock. Their NXGN share price forecasts range from $17.00 to $25.00. On average, they predict the company's stock price to reach $22.41 in the next year. This suggests that the stock has a possible downside of 5.5%.
View analysts price targets for NXGN or view top-rated stocks among Wall Street analysts.

NextGen Healthcare's stock was trading at $18.78 at the start of the year. Since then, NXGN stock has increased by 26.4% and is now trading at $23.73.
View the best growth stocks for 2023 here.

NextGen Healthcare saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 4,300,000 shares, an increase of 34.4% from the August 31st total of 3,200,000 shares. Based on an average daily trading volume, of 1,030,000 shares, the days-to-cover ratio is currently 4.2 days. Approximately 7.9% of the shares of the stock are short sold.
View NextGen Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
View our NXGN earnings forecast.

NextGen Healthcare, Inc. (NASDAQ:NXGN) announced its quarterly earnings results on Monday, July, 24th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.02. The firm earned $178.21 million during the quarter, compared to analyst estimates of $173.45 million. NextGen Healthcare had a trailing twelve-month return on equity of 10.09% and a net margin of 0.35%. The company's revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.06 earnings per share.

ETFs with the largest weight of NextGen Healthcare (NASDAQ:NXGN) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) and Fidelity Digital Health ETF (FDHT).Invesco S&P SmallCap Health Care ETF (PSCH).

NextGen Healthcare issued an update on its FY 2024 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $1.04-$1.11 for the period, compared to the consensus estimate of $1.08. The company issued revenue guidance of $714.00 million-$722.00 million, compared to the consensus revenue estimate of $717.95 million.

248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

NextGen Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.92%), Dimensional Fund Advisors LP (3.75%), State Street Corp (3.06%), William Blair Investment Management LLC (2.93%), Geode Capital Management LLC (1.67%) and Kennedy Capital Management LLC (1.40%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends.

Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NXGN stock can currently be purchased for approximately $23.73.

NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.59 billion and generates $653.17 million in revenue each year. The company earns $-2,650,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.

The company employs 2,783 workers across the globe.

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (949) 255-2600, via email at ir@nextgen.com, or via fax at 949-255-2605.